These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37205177)

  • 1. Pterostilbene-isothiocyanate reduces miR-21 level by impeding Dicer-mediated processing of pre-miR-21 in 5-fluorouracil and tamoxifen-resistant human breast cancer cell lines.
    Kumar V; Haldar S; Saini S; Ghosh S; Dhankhar P; Roy P
    3 Biotech; 2023 Jun; 13(6):193. PubMed ID: 37205177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pterostilbene-isothiocyanate inhibits breast cancer metastasis by selectively blocking IKK-β/NEMO interaction in cancer cells.
    Kumar V; Haldar S; Das NS; Ghosh S; Dhankhar P; Sircar D; Roy P
    Biochem Pharmacol; 2021 Oct; 192():114717. PubMed ID: 34352281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer activities of pterostilbene-isothiocyanate conjugate in breast cancer cells: involvement of PPARγ.
    Nikhil K; Sharan S; Singh AK; Chakraborty A; Roy P
    PLoS One; 2014; 9(8):e104592. PubMed ID: 25119466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pterostilbene-isothiocyanate impedes RANK/TRAF6 interaction to inhibit osteoclastogenesis, promoting osteogenesis in vitro and alleviating glucocorticoid induced osteoporosis in rats.
    Kumar V; Haldar S; Ghosh S; Chauhan S; Sharma A; Dhankhar P; Kumar A; Jaiswal S; Saini S; Gupta S; Lahiri D; Roy P
    Biochem Pharmacol; 2022 Dec; 206():115284. PubMed ID: 36209841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pterostilbene-Isothiocyanate Inhibits Proliferation of Human MG-63 Osteosarcoma Cells via Abrogating β-Catenin/TCF-4 Interaction-A Mechanistic Insight.
    Kumar V; Haldar S; Ghosh S; Saini S; Dhankhar P; Roy P
    ACS Omega; 2023 Nov; 8(46):43474-43489. PubMed ID: 38027335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-3646 Contributes to Docetaxel Resistance in Human Breast Cancer Cells by GSK-3β/β-Catenin Signaling Pathway.
    Zhang X; Zhong S; Xu Y; Yu D; Ma T; Chen L; Zhao Y; Chen X; Yang S; Wu Y; Tang J; Zhao J
    PLoS One; 2016; 11(4):e0153194. PubMed ID: 27045586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism underlying resistance to 5-fluorouracil and its reversal by the inhibition of thymidine phosphorylase in breast cancer cells.
    Mori R; Ukai J; Tokumaru Y; Niwa Y; Futamura M
    Oncol Lett; 2022 Sep; 24(3):311. PubMed ID: 35949616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences of time-dependent microRNA expressions in breast cancer cells.
    Bozkurt SB; Ozturk B; Kocak N; Unlu A
    Noncoding RNA Res; 2021 Mar; 6(1):15-22. PubMed ID: 33385103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of isothiocyanate conjugate of pterostilbene on the inhibition of MCF-7 cell proliferation and tumor growth in Ehrlich ascitic cell induced tumor bearing mice.
    Nikhil K; Sharan S; Chakraborty A; Bodipati N; Krishna Peddinti R; Roy P
    Exp Cell Res; 2014 Jan; 320(2):311-28. PubMed ID: 24216289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Andrographolide Exhibits Anticancer Activity against Breast Cancer Cells (MCF-7 and MDA-MB-231 Cells) through Suppressing Cell Proliferation and Inducing Cell Apoptosis via Inactivation of ER-α Receptor and PI3K/AKT/mTOR Signaling.
    Tohkayomatee R; Reabroi S; Tungmunnithum D; Parichatikanond W; Pinthong D
    Molecules; 2022 May; 27(11):. PubMed ID: 35684480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Urothelial carcinoma-associated 1 enhances tamoxifen resistance in breast cancer cells through competitively inhibiting miR-18a].
    Li XN; Liu AH; Tang X; Ren Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Apr; 49(2):295-302. PubMed ID: 28416841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer effect of metformin on estrogen receptor-positive and tamoxifen-resistant breast cancer cell lines.
    Kim J; Lee J; Jang SY; Kim C; Choi Y; Kim A
    Oncol Rep; 2016 May; 35(5):2553-60. PubMed ID: 26986571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP3.
    Gan R; Yang Y; Yang X; Zhao L; Lu J; Meng QH
    Cancer Gene Ther; 2014 Jul; 21(7):290-6. PubMed ID: 24924200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic, anti-proliferative and apoptotic effects of noscapine on human estrogen receptor positive (MCF-7) and negative (MDA-MB-231) breast cancer cell lines.
    Kocak C; Kocak FE; Ozturk B; Tekin G; Vatansev H
    Bratisl Lek Listy; 2020; 121(1):43-50. PubMed ID: 31950839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.
    Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H
    Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-381 overcomes cisplatin resistance in breast cancer by targeting MDR1.
    Yi D; Xu L; Wang R; Lu X; Sang J
    Cell Biol Int; 2019 Jan; 43(1):12-21. PubMed ID: 30444043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-409 regulates the proliferation and invasion of breast cancer cell lines by targeting special AT-rich sequence-binding protein 1 (SATB1).
    Chen Z; Sang MX; Geng CZ; Jia HQ
    Bioengineered; 2022 May; 13(5):13045-13054. PubMed ID: 35611599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long noncoding RNA-ROR on tamoxifen resistance of breast cancer cells by regulating microRNA-205.
    Zhang HY; Liang F; Zhang JW; Wang F; Wang L; Kang XG
    Cancer Chemother Pharmacol; 2017 Feb; 79(2):327-337. PubMed ID: 28063065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of direct target genes of miR-7, miR-9, miR-96, and miR-182 in the human breast cancer cell lines MCF-7 and MDA-MB-231.
    Moazzeni H; Najafi A; Khani M
    Mol Cell Probes; 2017 Aug; 34():45-52. PubMed ID: 28546132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and molecular docking study of new pyrimidine-based hydrazones with selective anti-proliferative activity against MCF-7 and MDA-MB-231 human breast cancer cell lines.
    Badawi WA; Samir M; Fathy HM; Okda TM; Noureldin MH; Atwa GMK; AboulWafa OM
    Bioorg Chem; 2023 Sep; 138():106610. PubMed ID: 37210828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.